Robert W. Baird lowered shares of IBEX (NASDAQ:IBEX - Free Report) from an outperform rating to a neutral rating in a research note released on Monday morning, Marketbeat reports. The firm currently has $30.00 price target on the stock.
Separately, Royal Bank of Canada increased their price objective on IBEX from $21.00 to $24.00 and gave the company a "sector perform" rating in a report on Friday, February 7th.
Get Our Latest Stock Analysis on IBEX
IBEX Stock Up 1.0%
Shares of IBEX stock traded up $0.28 during trading hours on Monday, reaching $28.59. 157,826 shares of the stock were exchanged, compared to its average volume of 128,769. The firm has a market capitalization of $377.16 million, a P/E ratio of 13.42 and a beta of 0.74. IBEX has a 12-month low of $14.93 and a 12-month high of $32.08. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.44 and a quick ratio of 1.44. The business's fifty day moving average is $24.86 and its two-hundred day moving average is $22.94.
Insider Activity
In other IBEX news, Director Mohammedulla Khaishgi sold 12,600 shares of IBEX stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $26.96, for a total value of $339,696.00. Following the completion of the sale, the director now owns 115,112 shares in the company, valued at $3,103,419.52. The trade was a 9.87% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Robert Thomas Dechant sold 49,931 shares of IBEX stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $26.24, for a total value of $1,310,189.44. Following the completion of the transaction, the chief executive officer now directly owns 213,633 shares in the company, valued at $5,605,729.92. This represents a 18.94% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 85,131 shares of company stock worth $2,228,585 over the last 90 days. 6.72% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On IBEX
A number of institutional investors have recently made changes to their positions in IBEX. Barclays PLC lifted its holdings in shares of IBEX by 95.2% in the third quarter. Barclays PLC now owns 20,636 shares of the company's stock valued at $412,000 after buying an additional 10,062 shares during the period. JPMorgan Chase & Co. grew its holdings in IBEX by 386.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 19,345 shares of the company's stock valued at $387,000 after buying an additional 15,372 shares during the last quarter. Ritholtz Wealth Management grew its holdings in shares of IBEX by 76.9% during the 4th quarter. Ritholtz Wealth Management now owns 32,859 shares of the company's stock worth $706,000 after purchasing an additional 14,279 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of IBEX during the 4th quarter worth approximately $116,000. Finally, Exchange Traded Concepts LLC bought a new position in IBEX in the 4th quarter valued at $307,000. 81.24% of the stock is currently owned by institutional investors.
About IBEX
(
Get Free Report)
IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company products and services portfolio includes ibex Connect, that offers customer service, technical support, revenue generation, and other revenue generation outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that comprises digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience.
See Also
Before you consider IBEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IBEX wasn't on the list.
While IBEX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.